You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

68-Gallium DOTATATE

Showing 1 - 25 of 747
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

Recruiting
  • Metastic Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Studies on Tumors of the Thyroid

Recruiting
  • Hurthle Cell Thyroid Cancer
  • +4 more
  • 68-Gallium Dotatate
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

Recruiting
  • Ganglioneuroblastoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • CT (Computed Tomography)
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 3, 2022

Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)

Recruiting
  • Grade 1 Meningioma
  • +4 more
  • Gallium Ga 68-DOTATATE
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Neuroendocrine Tumors Trial in Beijing (Gallium-68 NODAGA-LM3 PET/CT, Gallium-68 DOTA-LM3 PET/CT, Gallium-68 DOTATATE PET/CT)

Completed
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-LM3 PET/CT
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 20, 2021

Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

Recruiting
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-JR11
  • Beijing, Beijing, China
  • +1 more
Jul 27, 2022

PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Recruiting
  • Cardiac Sarcoidosis
  • Gallium-68 DOTATATE
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 4, 2021

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium

Suspended
  • Prostate Adenocarcinoma
  • +2 more
  • Gallium Ga 68 DOTA-NeoBOMB1
  • Gallium Ga 68 PSMA-R2
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
May 3, 2022

Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

Terminated
  • Coronary Arteriosclerosis
  • injection of 68Ga-DOTATATE
  • Paris, France
    service de médecine nucléaire-Hôpital Bichat
Jun 29, 2022

Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Dec 16, 2022

Meningioma Trial in New York (Ga-68- DOTATATE, Ga-68-DOTATOC)

Recruiting
  • Meningioma
  • New York, New York
    Weill Cornell Medical College of Cornell University
Apr 10, 2022

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Recruiting
  • Neuroendocrine Tumors (NET)
  • 68Ga-HA-DOTATATE PET/CT imaging
  • Calgary, Alberta, Canada
    Foothills Medical Center 1403 29 St NW
Jan 4, 2023

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Neuroendocrine Tumors, Von Hippel-Lindau Syndrome, Hippel-Lindau Disease Trial run by the NCI (68Gallium DOTATATE, Radio-guided

Completed
Has Results
  • Neuroendocrine Tumors
  • +2 more
  • 68Gallium DOTATATE
  • Radio-guided surgery
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 8, 2019

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023